Close
Achema

Exalenz BreathID Platform technology’s liver application wins US patent

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Cryogenic Identification Solutions for Pharma Supply Chains

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's...

Predictive AI in Pharma Cold Chain Risk Management

Revolutionizing Cold Chain Management Through Artificial Intelligence The pharmaceutical industry...

Transforming Pharma Cold Chain Using IoT Real-Time Tracking

Transforming Pharmaceutical Cold Chain Through Connected Intelligence The pharmaceutical industry...

Pharma Supply Chain and Customs Clearance Solutions

The Critical Challenge of Pharmaceutical Customs Clearance The pharmaceutical industry...

The US Patent and Trademark Office has granted Exalenz Bioscience the first patent for its BreathID Platform technology’s method of evaluating the liver condition of a patient.

By computing and comparing breath test parameters, before and after ingestion of a test substrate, while collecting a continuous flow of the patient’s breath, Exalenz’s breath test liver application will assess the liver condition of a patient.

Exalenz CEO Lawrence Cohen said the company intends to develop a product pipeline based on the BreathID Technology Platform.

“It has been a busy summer. In July, we launched the BreathID Hp for the detection and management of the H. pylori bacteria,” Cohen added.

“We also established a new direct US sales team purposed to better service our valued customers. We are looking forward to continuing the momentum and to more exciting developments in the fall.”

Exalenz develops advanced diagnostic systems that use the continuous flow of a patient’s breath to diagnose and help manage digestive system and liver conditions.

 

Latest stories

Related stories

Cryogenic Identification Solutions for Pharma Supply Chains

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's...

Predictive AI in Pharma Cold Chain Risk Management

Revolutionizing Cold Chain Management Through Artificial Intelligence The pharmaceutical industry...

Transforming Pharma Cold Chain Using IoT Real-Time Tracking

Transforming Pharmaceutical Cold Chain Through Connected Intelligence The pharmaceutical industry...

Pharma Supply Chain and Customs Clearance Solutions

The Critical Challenge of Pharmaceutical Customs Clearance The pharmaceutical industry...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back